Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Capital Employed (2019 - 2025)

Silo Pharma (SILO) has disclosed Return on Capital Employed for 7 consecutive years, with 0.17% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 10.0% to 0.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17% through Dec 2025, down 10.0% year-over-year, with the annual reading at 0.16% for FY2025, 8.0% down from the prior year.
  • Return on Capital Employed hit 0.17% in Q4 2025 for Silo Pharma, up from 0.19% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.07% in Q4 2022 to a low of 0.62% in Q2 2024.
  • Historically, Return on Capital Employed has averaged 0.27% across 5 years, with a median of 0.19% in 2021.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 452bps in 2021 and later crashed -50bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.26% in 2021, then soared by 74bps to 0.07% in 2022, then tumbled by -637bps to 0.51% in 2023, then soared by 85bps to 0.08% in 2024, then tumbled by -127bps to 0.17% in 2025.
  • Business Quant data shows Return on Capital Employed for SILO at 0.17% in Q4 2025, 0.19% in Q3 2025, and 0.18% in Q2 2025.